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Copyright © 2008 JCBN Summary Eicosapentaenoic acid (EPA) is essential for normal cell growth, and may play an
important role in inflammatory and autoimmune disorders including rheumatoid arthritis. We
investigate that EPA could suppress the proliferation of fibroblast like synoviocytes in vitro.
We treated synoviocytes with 1 to 50 µM EPA and measured cell viabilities by the modified
MTT assay. We sorted the number of them in sub G1 stage by fluorescence-activated cell
sorting caliber. And we stained them by light green or Hoechst 33258, and investigate micro-
scopic appearance. The cell viabilities were decreased at 30 µM, 40 µM, and 50 µM of EPA
comparing to 0 µM of EPA. The half maximal concentration of synoviocytes inhibition was
approximately 25 µM. At day 1 and day 3, cell number was also decreased at 50 µM EPA com-
paring to control. FACS caliber indicated the number of synoviocytes in sub G1 stage did not
increase in each concentration of EPA. Hoechst staining indicated normal chromatin pattern
and no change in a nuclear morphology both in EPA treated synoviocytes and in untreated
synoviocytes. These findings suggest that EPA could suppress the proliferation of synoviocytes
in vivo dose dependently and time dependently, however, the mechanism is not due to apoptosis.
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Introduction
Long chain omega-3 polyunsaturated fatty acids (PUFAs)
including eicosapentaenoic acid (EPA) are essential for
normal cell growth, and may play an important role in the
prevention and treatment of coronary artery disease, hyper-
tension, cancer, and other inflammatory and autoimmune
disorders including rheumatoid arthritis [1]. The first
evidence of the important role of dietary intake of PUFAs in
inflammation was derived from epidemiological observa-
tions of the low incidence of autoimmune and inflammatory
disorders, such as psoriasis, asthma and type-1 diabetes, as
well as multiple sclerosis in a population of Inuit compared
with gender- and age-matched groups living in Denmark [2].
Inuit have a high dietary intake of long chain PUFAs
including eicosapentaenoic acid from seafood [3]. There are
at least 13 randomized controlled clinical trials that show
benefit from fish oil supplements in patients with rheuma-
toid arthritis (RA) [4]. A common feature of the studies has
been a reduction in symptoms and in the number of tender
joints. There was a reduction in the dose of analgesic anti-
inflammatory drugs [5]. In a subsequent meta-analysis,
morning stiffness was decreased, as well as the number of
tender joints. So, we investigate that EPA could suppress the
proliferation of fibroblast like synoviocytes in vitro.EPA Suppresses Proliferation of Synoviocytes
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Materials and Methods
We obtained synovial tissues from patients with RA who
received replacement surgery, and used synoviocytes at
passage of 3–6, when they showed fibroblastoid mor-
phology. We measured cell viability by using modified MTT
assay (WST-1 assay; Dojindo, Kumamoto, Japan). Synovio-
cytes were treated with 1–50 μM EPA in RPMI1640 with or
without 1% heat-inactivated fetal cow serum (FCS) on 96-
well plates at a density of 1 × 104 cells per plate, 35 mm
diameters plates at a density of 2 × 105 cells per plate, or
8 × 8 mm multi chamber slides at a density of 2 × 104 cells per
plate. Floating and adherent synoviocytes were harvested at
24 h later, were stained by propidium iodide and sorted with
fluorescence-activated cell sorting (FACS) caliber.
Second, we investigate microscopic appearance of
synoviocytes cultured with 50 μM of EPA and RPMI1640
with 1% FCS and onto 8 × 8 mm multichamber slides at a
density of 2 × 104 cells per plate. Adherent synoviocytes were
harvested at 24 h later and were stained by 0.5% light green.
We stained DNA chromatin by Hoechst 33258 (Dojindo).
Statistical Analysis
The cell viabilities of synoviocytes treated with 1–50 μM
EPA were analyzed by the Kruskal-Wallis test followed by
Dunn’s multiple comparison test. The cell viabilities and cell
number of synoviocytes treated with or without 50 μM EPA
were analyzed by paired t test at day 0, 1,3, and 5. p<0.05
was considered significantly different.
Results
The cell viabilities were decreased at 30 μM, 40 μM, and
50 μM of EPA comparing to 0 μM of EPA (p<0.001, Fig. 1A
and 1B). Twenty-four hours later, the number of synovio-
cytes was reduced the control group, and its half maximal
concentration of synoviocytes inhibition was approximately
25 μM (Fig. 2). At day 1 and day 3, cell number was also
decreased at 50 μM EPA comparing to control (Fig. 3).
FACS caliber indicated the number of synoviocytes in sub-
G1 stage didn’t increase in each concentration of EPA.
At 24 h later EPA-treated synoviocytes appears less active
and had an irregular or round shape compared with untreated
synoviocytes. Hoechst staining indicated normal chromatin
pattern and no change in a nuclear morphology both in
EPA-treated synoviocytes and in untreated synoviocytes.
Discussion
Our results suggest that EPA could suppress the prolifera-
tion of synoviocytes in vivo dose-dependently and time-
dependently, however, the mechanism is not due to
apoptosis.
In animals, omega-3 PUFA has also been found to reduce
the severity of experimental cerebral [6] and myocardial
infarction [7], to retard autoimmune nephritis and prolong
survival of NZB × NZW F1 mice [8,  9] and reduce the
incidence of breast tumors in rats [10]. The anti-inflammatory
aspects of omega-3 PUFAs relate to the regulation of
prostaglandin and cytokines [11]. EPA is a kind of cell
membrane phospholipid as well as arachidonic acid, which
is a kind of omega-6 PUFAs [11]. EPA increased PGE3
production and competed with arachidonic acid at the level
of incorporation into cell membrane phospholipid, and
suppressed the secretion of proinflammatory cytokines (IL-
1, TNF-α, IL-6) and COX-2 expression [11]. EPA and COX
inhibitor suppressed the expression of Bcl-2 in HL-60 cells,
corporately [11]. High concentration of EPA could suppress
the proliferation of colon cancer cell, breast cancer cell, and
Fig. 1. We seeded synoviocytes (1 × 104 cell/well, n = 5) onto
96-well plates of 0–50 μM of EPA and RPMI1640
without FCS and 0–50 μM of EPA (A) or RPMI1640
with 1% incubated FCS (B). After 24 h, we measured
cell viabilities by the modified MTT assay (WST-1 assay;
Dojindo, Japan). The cell viabilities were decreased at
30 μM, 40 μM, and 50 μM of EPA comparing to 0 μM
of EPA (*p<0.01, **p<0.001). Data was expressed at
mean ± SD.M. Hamaguchi et al.
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prostate cancer cell [11]. Moreover, EPA could induce
apoptosis in carcinoma cells of malignant lymphoma and
leukemia [11]. The pathway of cell death is different on the
basis of cell line [11]. Six hours after single intake of 900 mg
of EPA, the serum concentration of EPA reaches 153.7 μg/
mL (=485 μM). EPA exists in normal human body at
33.33 μg/mL (=105 μM). When we intake EPA (2700 mg
per day, 3 times per day) everyday, the effective serum
concentration of EPA reaches 159.79 μg/mL (=μM). We
show that 25 μM of EPA can suppress the proliferation of
synoviocytes in patients with RA, however, the death
pathway of synoviocytes is not through apoptosis. Synovial
hyperplasia has been characterized as a tumor-like prolifera-
tion and is thought to be a major cause of destruction of
cartilage and bone. Increased proliferation and insufficient
apoptosis of synovial cell might contribute to its expansion
so elimination of proliferating synoviocytes in the rheumatoid
synovium seems to be a potentially effective treatment for
RA. In this way, EPA is effective for a lot of diseases by
regulating the cell cycle and imuuno-inflammatory reaction.
The mechanism, in particular the suppression of cell growth,
is not clarified in detail, however to clarify this matter will
lead to new aspects for pathogenesis and therapy for various
diseases.
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Fig. 2. Synoviocytes (1 × 104 cell/well, n = 5) were seeded onto
96-well plates of RPMI 1640 and 1% heat-inactivated
FCS with or without 50 μM EPA. Cell viabilities were
measured by the modified MTT assay at day 0, 1, 3, 5.
At day 1, 3, 5, cell viabilities were decreased at 50 μM
of EPA comparing to 0 μM of EPA (p<0.001). Data was
expressed at mean ± SD.
Fig. 3. Synoviocytes (2 × 105 cells/well, n = 5) were seeded
onto 35 mm diameter plates of RPMI1640 and 5% or
10% heat-inactivated FCS with or without 50 μM EPA.
Floating and adherent synoviocytes were harvested and
counted at day 1 and 3. Cell number was decreased at
50 μM EPA comparing to 0 μM EPA at both day 1 and
day 3 (*p<0.01, **p<0.05). Data represent mean ± SD.